Skip to main content
[Preprint]. 2023 Feb 23:2023.02.16.23285997. [Version 1] doi: 10.1101/2023.02.16.23285997

Table 1.

Overview of the characteristics of the study population

Women Men
Mean / N SD / % N Mean / N SD / % N
Characteristics
Study FHS 665 62.6 1062 1,088 67.5 1612
InCHIANTI 193 18.2 222 13.8
BLSA 204 19.2 302 18.7
Age at sex hormone measurement years 66.5 9.8 1062 62.4 12.2 1612
Age at DNA methylation years 70.6 8.9 1062 66.9 11.6 1612
Time between visits among FHS years 6.6 0.6 665 6.6 0.7 1088
Age of menopause years 48.6 6.0 991 NA
Time since menopause at sex hormone measurements years 17.3 11.0 991 NA
Smoking status at sex hormone measurements never 437 40.7 1075 485 29.9 1624
Former/current 638 59.3 1,139 70.1
Packyears at sex hormone measurements among smokers pack-years 17.8 18.4 638 24.1 20.8 1139
Alcohol intake Drinks/weeks 7.0 9.2 1015 19.4 24.2 1488
BMI at sex hormone measurement kg/m2 27.5 5.2 1073 28.3 4.4 1622
Hormone levels
Total estrone pg/ml 32.2 20.9 634 50.6 17.7 1037
Total estradiol pg/ml 11.0 19.6 984 23.9 10.1 1519
SHBG nmol/L 83.3 49.4 832 61.7 31.5 1260
Total testosterone ng/dl 35.4 28.0 1017 541.3 226.6 1533
DHEAS ug/dl 86.2 71.4 192 143.1 115.6 221
Bioavailable sex hormones
Bioavailable estrone pg/ml 1.0 0.7 633 1.8 0.6 1037
Bioavailable estradiol pg/ml 0.2 0.3 812 0.5 0.2 1250
Bioavailable testosterone pg/ml 4.0 3.0 829 82.7 35.0 1259
Main outcome
Pheno AA years −0.7 6.4 1075 0.8 6.1 1624
Grim AA years −1.6 4.0 1075 1.7 4.5 1624
DNAm PAI1 pg/ml 19021 2862 1075 20865 3117 1624
DNAm Leptin pg/ml 12026 2839 1075 4769 1648 1624

Abbreviations: N: Number; SD: Standard Deviation; years: years; NA: Not applicable; FHS: Framingham Heart Study; BLSA: Baltimore Longitudinal Study of Aging